Literature DB >> 10566984

Leptin-induced increase in sympathetic nervous and cardiovascular tone is mediated by proopiomelanocortin (POMC) products.

J C Dunbar1, H Lu.   

Abstract

The mechanism underlying the leptin-induced increased sympathetic nerve activity and cardiovascular tone was investigated in normal rats. The melanocortin (MC) peptides and other fragments derived from proopiomelancortin (POMC) have a diverse array of biological activities and have been implicated in mediating the feeding behavioral responses to leptin. In this study we evaluated the possible involvement of two major products of POMC, alpha-melanocyte stimulating hormone (alpha-MSH) and beta-endorphin, in mediating the effects of leptin on sympathetic activity and mean arterial pressure (MAP) in normal rats. Intraventricular (i.c.v.) cannulas were implanted in normal rats and allowed to recover. On the day of the study the animals were anesthetized with urethane alpha-chloralose and instrumented for the recording of MAP, lumbar sympathetic nerve activity (LSNA), and heart rate (HR). To determine the correlation between the leptin response and the POMC products, alpha-MSH and beta-endorphins were also injected into the lateral ventricle. alpha-MSH acted to increase MAP and LSNA while beta-endorphin decreased these parameters. Leptin administration by i.c.v. cannula increased the MAP and LSNA in normal rats. The i.c.v. administration of agouti protein, an alpha-MSH receptor antagonist, prior to leptin infusion blocked this response. Likewise, pretreatment with naloxone a beta-endorphin receptor antagonist also blocked the response to leptin. From these studies we conclude that the acute increased LSNA and MAP in response to i.c.v. leptin may be mediated by increased POMC and its subsequent production of breakdown product alpha-MSH and/or beta-endorphin and it is the subsequent action of alpha-MSH that increases MAP and LSNA by activation of the MC4 receptor. The naloxone antagonism of the leptin response is likely due to the blockade of presynaptic opioid inhibition of the MC4 receptor-mediated pressor response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10566984     DOI: 10.1016/s0361-9230(99)00197-5

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  23 in total

1.  The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine.

Authors:  Aaron N A Verty; Malini E Singh; Iain S McGregor; Paul E Mallet
Journal:  Psychopharmacology (Berl)       Date:  2003-04-17       Impact factor: 4.530

2.  Leptin differentially increases sympathetic nerve activity and its baroreflex regulation in female rats: role of oestrogen.

Authors:  Zhigang Shi; Virginia L Brooks
Journal:  J Physiol       Date:  2014-12-22       Impact factor: 5.182

3.  The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist.

Authors:  Gina L C Yosten; Willis K Samson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-03-24       Impact factor: 3.619

Review 4.  Central nervous system dysfunction in obesity-induced hypertension.

Authors:  Geoffrey A Head; Kyungjoon Lim; Benjamin Barzel; Sandra L Burke; Pamela J Davern
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

5.  Prolyl carboxypeptidase regulates energy expenditure and the thyroid axis.

Authors:  Jin Kwon Jeong; Gyorgyi Szabo; Kaitlin Kelly; Sabrina Diano
Journal:  Endocrinology       Date:  2011-12-27       Impact factor: 4.736

6.  Preoperative Serum Leptin Level Is Associated with Preoperative Pain Threshold and Postoperative Analgesic Consumption in Patients Undergoing Cesarean Section.

Authors:  Nurten Seringec Akkececi; Gozen Oksuz; Aykut Urfalioğlu; Ramazan Gunesacar; Murat Bakacak; Mahmut Arslan; Bekir Mehmet Kelleci
Journal:  Med Princ Pract       Date:  2019-04-26       Impact factor: 1.927

7.  Neuroanatomy of melanocortin-4 receptor pathway in the lateral hypothalamic area.

Authors:  Huxing Cui; Jong-Woo Sohn; Laurent Gautron; Hisayuki Funahashi; Kevin W Williams; Joel K Elmquist; Michael Lutter
Journal:  J Comp Neurol       Date:  2012-12-15       Impact factor: 3.215

Review 8.  Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.

Authors:  Alexandre A da Silva; Jussara M do Carmo; Xuan Li; Zhen Wang; Alan J Mouton; John E Hall
Journal:  Can J Cardiol       Date:  2020-02-12       Impact factor: 5.223

9.  Antagonism of the melanocortin system reduces cold and mechanical allodynia in mononeuropathic rats.

Authors:  D H Vrinten; W H Gispen; G J Groen; R A Adan
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

Review 10.  Exercise therapy in type 2 diabetes.

Authors:  Stephan F E Praet; Luc J C van Loon
Journal:  Acta Diabetol       Date:  2009-05-29       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.